Related Experiment Video
Updated: Jun 5, 2026
13:51
Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay
Published on: November 11, 2018
Simvastatin modulates the adhesion and growth of hepatocellular carcinoma cells via decrease of integrin expression
Borna Relja1, Frank Meder, Minhong Wang
1Department of Trauma, Hand and Reconstructive Surgery, Hospitals of the Goethe-University Frankfurt am Main, 60590 Frankfurt, Germany. info@bornarelja.com
International Journal of Oncology
|January 6, 2011
Summary
Simvastatin, a cholesterol-lowering drug, inhibits hepatocellular carcinoma (HCC) cell growth and adhesion by reducing key cell adhesion molecules and Rho-dependent kinase (ROCK) activity. These findings suggest simvastatin as a potential novel treatment for HCC.
Area of Science:
- Oncology
- Pharmacology
- Cell Biology
Background:
- Hepatocellular carcinoma (HCC) is a major global health concern and a leading cause of cancer mortality.
- Simvastatin, a 3-hydroxy-3-methyl-glutarylcoenzyme-A (HMG-CoA) reductase inhibitor, has demonstrated potential anticancer properties.
- The precise mechanism of simvastatin's action in HCC remains incompletely understood.
Purpose of the Study:
- To investigate the effects of simvastatin on HCC cell growth and adhesion.
- To elucidate the underlying mechanism of simvastatin's action in HCC.
- To evaluate the role of integrins and Rho-dependent kinase (ROCK) in simvastatin's anti-cancer effects.
Main Methods:
- HepG2 and Huh7 HCC cell lines were treated with simvastatin.
- Cell proliferation was assessed using the MTT assay.
- Cell adhesion to endothelial cells, integrin expression (ß1, ß3, α2), and ROCK pathway activation (ROCK-I, p-MYPT) were analyzed via Western blot and blocking studies.
Main Results:
- Simvastatin significantly inhibited HCC cell growth and adhesion to endothelium in a dose-dependent manner.
- Simvastatin treatment led to decreased expression of ß1, ß3, and α2 integrins.
- Simvastatin reduced ROCK-I expression and MYPT activation, and ROCK inhibition mimicked simvastatin's anti-adhesive effects.
Conclusions:
- Simvastatin exerts anti-cancer effects in HCC by modulating cell adhesion molecules and inhibiting the ROCK pathway.
- These findings highlight simvastatin's potential as a novel therapeutic agent for hepatocellular carcinoma.
- The study identifies specific molecular targets and pathways involved in simvastatin's anti-HCC activity.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:15Activation of Integrins
Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
01:17Intracellular Signaling Affects Focal Adhesions
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
01:10Integrins
Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...